Clinical Trial for LB-DTK-MV in Antiviral-Resistant Infections Post-Anticancer Therapy
A clinical trial is underway to evaluate the safety and efficacy of LB-DTK-MV in patients with antiviral-resistant CMV, BKV, or EBV infections following anticancer therapy.